Fill in the form below and our experts will get back to you within 1 business day.
CD Biosynsis engineers microorganisms for advanced materials with tailored properties. From bio-adhesives and functional coatings to smart materials, we develop biological routes to performance materials that outperform conventional synthetics.
Serving the Advanced Materials Industry
Materials Companies
Bio-based material developers
Adhesive Manufacturers
Sustainable bonding solutions
Coatings Industry
Functional surface treatments
Composite Producers
Bio-reinforced materials
End-to-end capabilities for bio-derived materials engineering
Mussel-inspired and natural adhesive proteins
Antimicrobial and responsive surface materials
Bacterial cellulose and bio-fiber reinforcement
Responsive and self-healing systems
Materials science demands high performance with sustainable end-of-life. Our platform engineers biological materials achieving properties difficult or impossible through traditional chemistry.
Conventional materials often trade performance for sustainability. Synthetic biology enables property optimization without compromise, achieving high performance in bio-derived formats.
Materials persistence drives environmental concern. Engineered microbes produce materials designed for controlled degradation at end-of-life while maintaining in-use performance.
Modern applications require integrated mechanical, thermal, and functional properties. Our platform achieves multi-functionality through genetic programming of biological systems.
Platform Approach
40% faster development
We engineer microbial systems for advanced materials production with properties difficult to achieve through traditional chemistry, including self-healing, stimuli-responsiveness, and engineered biodegradation.
Engineer mussel-inspired proteins, curli nanofibers, and barnacle cement analogs for biomedical, packaging, and structural bonding applications.
Develop antimicrobial, anti-fouling, and responsive coating systems using engineered biofilm components for active surface functionality.
Engineer Komagataeibacter strains for enhanced yield and properties for wound dressings, composites, and food applications.
Combine bio-derived matrices with natural fibers for fully biodegradable composites with engineered interfacial bonding.
Engineer microorganisms producing healing agents for autonomous damage repair extending service life and reducing maintenance. Bacillus subtilis spores provide robust self-healing functionality.
Develop temperature, pH, or light-responsive materials through engineered production for drug delivery, sensing, and adaptive applications.
Why materials science is embracing biological production
| Parameter | Chemical Inputs | Synthetic Biology |
|---|---|---|
| Production Conditions | Energy-intensive chemical synthesis | Ambient temperature fermentation |
| Property Tunability | Optimized through petrochemical processing | Precision sequencing and macromolecular hierarchy control |
| Environmental Persistence | Designed for durability, persisting in waste | Engineered for controlled degradation |
| Resource Efficiency | Derived from non-renewable petroleum | Produced from renewable biomass |
| Functional Complexity | Limited functional group diversity | Access to complex biological structures |
Integrated capabilities for high-performance bio-derived materials development.
Recombinant protein design for material applications
Downstream processing and material forming technologies
Mechanical, thermal, and functional property testing
End-use performance validation under relevant conditions
We function as your external strain engineering and metabolic pathway team. Whether you need a single engineered chassis or a complete pathway optimization pipeline, we deliver publication-quality data and transfer-ready strains.
Each project is assigned a dedicated PhD-level scientist as primary contact, ensuring technical continuity and rapid decision-making throughout development.
Engage us for full end-to-end development or specific phases (strain engineering only, fermentation optimization only, etc.). Scale investment according to your validation needs.
All proprietary strains and sequences remain your exclusive property. We offer clean IP transfer with no residual license claims or downstream revenue sharing requirements.
In-house regulatory affairs team experienced with TSCA, FDA FCN, and REACH guidelines. We prepare submission-ready dossiers for your target markets.
Concept to pilot validation. Includes strain engineering, fermentation optimization, and greenhouse testing.
Genetic modification and characterization. Deliverables include sequence-confirmed strains and technical reports.
Process development and optimization. From lab-scale proof to pilot-scale production parameters.
Characterization, stability testing, and regulatory dossier preparation for submission.
Get answers to common questions about our advanced materials solutions. our team for project-specific inquiries.
Bacterial cellulose achieves tensile strengths of 100-300 MPa with flexibility. Bio-adhesives reach bonding strengths exceeding 2 MPa on wood substrates. We work with clients to establish and engineer toward target specifications.
Yes, degradation is controlled through composition, crystallinity, and protective modifications. We engineer materials with programmed degradation from weeks (packaging) to years (structural applications).
Many bio-derived materials meet or exceed conventional alternatives for specific applications. Our development includes testing against ASTM, ISO standards and comparative benchmarking.
Economic viability depends on material value and production cost. High-value specialties may be viable at pilot scale (1000L). Commodity applications require industrial-scale fermentation. We assess economics during feasibility studies.
Regulatory classification depends on your final product and modification approach. We can engineer strains using methods that may qualify for streamlined review (e.g., self-cloning, site-directed mutagenesis). Our regulatory team provides guidance on TSCA, FDA FCN, and REACH requirements during the project design phase to ensure your strain aligns with your intended regulatory pathway.
Get a customized quote for your Materials project. Our experts will respond within 24 hours.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.